Roth MKM keeps a Buy rating and $120 price target on Live Nation while noting that the DOJ’s antitrust case against the company faces an “uphill battle” and will have difficulty in succeeding. The company believes it has acted in accordance with its consent decree, and while the management is willing to discuss certain remedies, these are not expected to be transformative for the business, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LYV:
- 3 Best Stocks to Buy Now, 5/24/2024, According to Top Analysts
- Live Nation Stock (LYV) Falls as Antitrust Lawsuit Looms
- Live Nation falls 8% to $93.00 after Bloomberg report of pending DOJ suit
- Live Nation sinks 8% to $93 following reports of DOJ antitrust suit
- Justice Department, states to sue Live Nation for antitrust, Bloomberg says